BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang J, Pei H, Luo H, Fu A, Yang H, Hu J, Zhao C, Chai L, Chen X, Shao X, Wang C, Wu W, Wan L, Ye H, Qiu Q, Peng A, Wei Y, Yang L, Chen L. Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways. Oncotarget 2017;8:915-32. [PMID: 27906672 DOI: 10.18632/oncotarget.13687] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Sant'ana DC, Pereira JPC, Cesar PHS, Trento MVC, Braga MA, Borges BDB, Marcussi S. How do phenolic compounds act in the prevention and treatment of cancer? Revista Científica Multidisciplinar Núcleo do Conhecimento 2022. [DOI: 10.32749/nucleodoconhecimento.com.br/health/phenolic-compounds] [Reference Citation Analysis]
2 Sauzeau V, Beignet J, Vergoten G, Bailly C. Overexpressed or hyperactivated Rac1 as a target to treat hepatocellular carcinoma. Pharmacol Res 2022;:106220. [PMID: 35405309 DOI: 10.1016/j.phrs.2022.106220] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Targen S, Konu O. Zebrafish Xenotransplantation Models for Studying Gene Function and Drug Treatment in Hepatocellular Carcinoma. J Gastrointest Cancer 2022. [PMID: 35031971 DOI: 10.1007/s12029-021-00782-z] [Reference Citation Analysis]
4 Enaru B, Socaci S, Farcas A, Socaciu C, Danciu C, Stanila A, Diaconeasa Z. Novel Delivery Systems of Polyphenols and Their Potential Health Benefits. Pharmaceuticals (Basel) 2021;14:946. [PMID: 34681170 DOI: 10.3390/ph14100946] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
5 Ezzeldeen Y, Swidan S, ElMeshad A, Sebak A. Green Synthesized Honokiol Transfersomes Relieve the Immunosuppressive and Stem-Like Cell Characteristics of the Aggressive B16F10 Melanoma. Int J Nanomedicine 2021;16:5693-712. [PMID: 34465990 DOI: 10.2147/IJN.S314472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Tonon F, Farra R, Zennaro C, Pozzato G, Truong N, Parisi S, Rizzolio F, Grassi M, Scaggiante B, Zanconati F, Bonazza D, Grassi G, Dapas B. Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules. Pharmaceuticals (Basel) 2021;14:803. [PMID: 34451900 DOI: 10.3390/ph14080803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Okuda K, Umemura A, Umemura S, Kataoka S, Taketani H, Seko Y, Nishikawa T, Yamaguchi K, Moriguchi M, Kanbara Y, Arbiser JL, Shima T, Okanoue T, Karin M, Itoh Y. Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor-MIG6 Axis. Cancers (Basel) 2021;13:1515. [PMID: 33806040 DOI: 10.3390/cancers13071515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Metawea ORM, Abdelmoneem MA, Haiba NS, Khalil HH, Teleb M, Elzoghby AO, Khafaga AF, Noreldin AE, Albericio F, Khattab SN. A novel 'smart' PNIPAM-based copolymer for breast cancer targeted therapy: Synthesis, and characterization of dual pH/temperature-responsive lactoferrin-targeted PNIPAM-co-AA. Colloids Surf B Biointerfaces 2021;202:111694. [PMID: 33740633 DOI: 10.1016/j.colsurfb.2021.111694] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 19.0] [Reference Citation Analysis]
9 Zhang S, Mo Z, Zhang S, Li X. A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Artemisia annua on the Treatment of Hepatocellular Carcinoma. Evid Based Complement Alternat Med 2021;2021:8947304. [PMID: 33688369 DOI: 10.1155/2021/8947304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Pai JT, Hsu CY, Hsieh YS, Tsai TY, Hua KT, Weng MS. Suppressing migration and invasion of H1299 lung cancer cells by honokiol through disrupting expression of an HDAC6-mediated matrix metalloproteinase 9. Food Sci Nutr 2020;8:1534-45. [PMID: 32180962 DOI: 10.1002/fsn3.1439] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
11 Singh M, Devi S, Rana VS, Mishra BB, Kumar J, Ahluwalia V. Delivery of phytochemicals by liposome cargos: recent progress, challenges and opportunities. J Microencapsul 2019;36:215-35. [PMID: 31092084 DOI: 10.1080/02652048.2019.1617361] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
12 Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB. Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets. Pharmacological Research 2019;144:192-209. [DOI: 10.1016/j.phrs.2019.04.004] [Cited by in Crossref: 93] [Cited by in F6Publishing: 87] [Article Influence: 31.0] [Reference Citation Analysis]
13 Zhou C, Guo C, Li W, Zhao J, Yang Q, Tan T, Wan Z, Dong J, Song X, Gong T. A novel honokiol liposome: formulation, pharmacokinetics, and antitumor studies. Drug Development and Industrial Pharmacy 2018;44:2005-12. [DOI: 10.1080/03639045.2018.1506475] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
14 Wu W, Tang MH, Tang H, Chen K, Fu J, Wang L, Xue LL, Peng A, Ye H, Chen LJ. Identification, characterization and HPLC quantification of formulation-related impurities of honokiol, an antitumor natural drug candidate in clinical trials. J Pharm Biomed Anal 2018;153:186-92. [PMID: 29499462 DOI: 10.1016/j.jpba.2018.02.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Maioli M, Basoli V, Carta P, Fabbri D, Dettori MA, Cruciani S, Serra PA, Delogu G. Synthesis of magnolol and honokiol derivatives and their effect against hepatocarcinoma cells. PLoS One. 2018;13:e0192178. [PMID: 29415009 DOI: 10.1371/journal.pone.0192178] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
16 Zhu L, Liu R, Zhang W, Qian S, Wang J. Application of EGFR inhibitor reduces circulating tumor cells during transcatheter arterial embolization. Clin Transl Oncol 2018;20:639-46. [DOI: 10.1007/s12094-017-1761-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]